Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L N Horowitz

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
The American Journal of Cardiology|December 1, 1986
Are there unnecessary delays in the development of new cardiac drugs in the United States?J Morganroth, L N Horowitz
The American Journal of Cardiology|September 1, 1982
Can we prevent sudden cardiac death?L N Horowitz, J Morganroth
The American Journal of Cardiology|November 1, 1984
Use of intravenous verapamil for ventricular tachycardiaB Belhassen, L N Horowitz
The American Journal of Cardiology|October 1, 1985
Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmiasJ Morganroth, L N Horowitz
The American Journal of Cardiology|February 27, 1984
Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogramJ Morganroth, L N Horowitz
Hospital Practice|September 1, 1980
Recurrent ventricular tachycardia: an electrophysiologic approachM E Josephson, L N Horowitz
Geriatrics|April 1, 1991
Managing geriatric arrhythmias, II: Drug selection and useR A Lynch, L N Horowitz
Geriatrics|March 1, 1991
Managing geriatric arrhythmias, I: General considerationsL N Horowitz, R A Lynch
Progress in Cardiovascular Diseases|March 1, 1989
Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmiasH A Kopelman, L N Horowitz
The American Journal of Cardiology|March 1, 1979
Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardiaM E Josephson, L N Horowitz
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
The American Journal of Cardiology|December 1, 1986
Are there unnecessary delays in the development of new cardiac drugs in the United States?J Morganroth, L N Horowitz
The American Journal of Cardiology|September 1, 1982
Can we prevent sudden cardiac death?L N Horowitz, J Morganroth
The American Journal of Cardiology|November 1, 1984
Use of intravenous verapamil for ventricular tachycardiaB Belhassen, L N Horowitz
The American Journal of Cardiology|October 1, 1985
Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmiasJ Morganroth, L N Horowitz
The American Journal of Cardiology|February 27, 1984
Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogramJ Morganroth, L N Horowitz
Hospital Practice|September 1, 1980
Recurrent ventricular tachycardia: an electrophysiologic approachM E Josephson, L N Horowitz
Geriatrics|April 1, 1991
Managing geriatric arrhythmias, II: Drug selection and useR A Lynch, L N Horowitz
Geriatrics|March 1, 1991
Managing geriatric arrhythmias, I: General considerationsL N Horowitz, R A Lynch
Progress in Cardiovascular Diseases|March 1, 1989
Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmiasH A Kopelman, L N Horowitz
The American Journal of Cardiology|March 1, 1979
Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardiaM E Josephson, L N Horowitz
Pageof 16